Drugs / Oxaprozin
Oxaprozin
also known as
Coxanto · Daypro · Daypro alta · NSC-310839 · OXAPROZIN POTASSIUM · Oxaprozina · Oxaprozine · WY-21,743
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | DAYPRO | — | 2002-01-25 | fda.gov ↗ |
| Approved | US (FDA) | DAYPRO | — | 1992-10-29 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03350386 | Nov → Dec 2017 | — | Mochida Pharmaceutical Company, Ltd. | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Oxaprozin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03350386 ↗ |
| Known as | Coxanto | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | Daypro | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | Daypro alta | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | NSC-310839 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | OXAPROZIN POTASSIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | Oxaprozina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | Oxaprozine | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Known as | WY-21,743 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1071 ↗ |
| Modality | Small molecule | — CHEMBL1071 ↗ |